Shares Outstanding Shares Outstanding n/a Close	18.62M
Shares Change (YoY) Shares Change (YoY) n/a Close	-0.77%
Shares Change (QoQ) Shares Change (QoQ) n/a Close	-0.81%
Owned by Institutions (%) Owned by Institutions (%) n/a Close	56.51%
Shares Floating Shares Floating n/a Close	n/a
Failed to Deliver (FTD) Shares Failed to Deliver (FTD) Shares n/a Close	81
FTD / Avg. Volume FTD / Avg. Volume n/a Close	0.04%

Short Selling Information

The latest short interest is 956.2K, so 5.13% of the outstanding shares have been sold short.

Short Interest Short Interest n/a Close	956.2K
Short % of Shares Out Short % of Shares Out n/a Close	5.13%
Short % of Float Short % of Float n/a Close	8.87%
Short Ratio (days to cover) Short Ratio (days to cover) n/a Close	4.07

Valuation Ratios

The PE ratio is 16.19 and the forward PE ratio is 8.77. USANA Health Sciences's PEG ratio is -0.48.

PE Ratio PE Ratio n/a Close	16.19
Forward PE Forward PE n/a Close	8.77
PS Ratio PS Ratio n/a Close	0.8
Forward PS Forward PS n/a Close	0.5
PB Ratio PB Ratio n/a Close	1.28
P/FCF Ratio P/FCF Ratio n/a Close	13.36
PEG Ratio PEG Ratio n/a Close	-0.48

Financial Ratio History

Enterprise Valuation

USANA Health Sciences has an Enterprise Value (EV) of 527.64M.

EV / Sales EV / Sales n/a Close	0.62
EV / EBITDA EV / EBITDA n/a Close	5.34
EV / EBIT EV / EBIT n/a Close	8.65
EV / FCF EV / FCF n/a Close	10.36

Financial Position

The company has a current ratio of 2, with a Debt / Equity ratio of 0.05.

Current Ratio Current Ratio n/a Close	2
Quick Ratio Quick Ratio n/a Close	1.5
Debt / Equity Debt / Equity n/a Close	0.05
Debt / EBITDA Debt / EBITDA n/a Close	0.29
Debt / FCF Debt / FCF n/a Close	0.57
Interest Coverage Interest Coverage n/a Close	236.03

Financial Efficiency

Return on Equity is 7.9% and Return on Invested Capital is 5.73%.

Return on Equity Return on Equity n/a Close	7.9%
Return on Assets Return on Assets n/a Close	5.62%
Return on Invested Capital Return on Invested Capital n/a Close	5.73%
Revenue Per Employee Revenue Per Employee n/a Close	$502,648.82
Profits Per Employee Profits Per Employee n/a Close	$24,723.53
Employee Count Employee Count n/a Close	1,700
Asset Turnover Asset Turnover n/a Close	1.14
Inventory Turnover Inventory Turnover n/a Close	2.31

Taxes

Income Tax Income Tax n/a Close	34.29M
Effective Tax Rate Effective Tax Rate n/a Close	44.91%

Stock Price Statistics

The stock price has increased by -40.69% in the last 52 weeks. The beta is 0.64, so USANA Health Sciences's price volatility has been higher than the market average.

Beta Beta n/a Close	0.64
52-Week Price Change 52-Week Price Change n/a Close	-40.69%
50-Day Moving Average 50-Day Moving Average n/a Close	27.69
200-Day Moving Average 200-Day Moving Average n/a Close	33.68
Relative Strength Index (RSI) Relative Strength Index (RSI) n/a Close	49.25
Average Volume (20 Days) Average Volume (20 Days) n/a Close	212,985

Income Statement

In the last 12 months, USANA Health Sciences had revenue of 854.5M and earned 42.03M in profits. Earnings per share was 2.2.

Revenue Revenue n/a Close	854.5M
Gross Profit Gross Profit n/a Close	693.29M
Operating Income Operating Income n/a Close	66.32M
Net Income Net Income n/a Close	42.03M
EBITDA EBITDA n/a Close	98.86M
EBIT EBIT n/a Close	76.63M
Earnings Per Share (EPS) Earnings Per Share (EPS) n/a Close	2.2

Full Income Statement

Balance Sheet

The company has 181.77M in cash and 29.01M in debt, giving a net cash position of 152.75M.

Cash & Cash Equivalents Cash & Cash Equivalents n/a Close	181.77M
Total Debt Total Debt n/a Close	29.01M
Net Cash Net Cash n/a Close	152.75M
Retained Earnings Retained Earnings n/a Close	478.94M
Total Assets Total Assets n/a Close	746.6M
Working Capital Working Capital n/a Close	144.01M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 60.99M and capital expenditures -10.07M, giving a free cash flow of 50.92M.

Operating Cash Flow Operating Cash Flow n/a Close	60.99M
Capital Expenditures Capital Expenditures n/a Close	-10.07M
Free Cash Flow Free Cash Flow n/a Close	50.92M
FCF Per Share FCF Per Share n/a Close	2.67

Full Cash Flow Statement

Margins

Gross margin is 81.13%, with operating and profit margins of 7.76% and 4.92%.

Gross Margin Gross Margin n/a Close	81.13%
Operating Margin Operating Margin n/a Close	7.76%
Pretax Margin Pretax Margin n/a Close	8.94%
Profit Margin Profit Margin n/a Close	4.92%
EBITDA Margin EBITDA Margin n/a Close	11.57%
EBIT Margin EBIT Margin n/a Close	7.76%
FCF Margin FCF Margin n/a Close	5.96%

Dividends & Yields

USNA does not appear to pay any dividends at this time.

Dividend Per Share Dividend Per Share n/a Close	n/a
Dividend Yield Dividend Yield n/a Close	n/a
Dividend Growth (YoY) Dividend Growth (YoY) n/a Close	n/a
Payout Ratio Payout Ratio n/a Close	n/a
Earnings Yield Earnings Yield n/a Close	6.18%
FCF Yield FCF Yield n/a Close	7.48%

Dividend Details

Analyst Forecast

The average price target for USNA is $36, which is 24.2% higher than the current price. The consensus rating is "Hold".

Price Target Price Target n/a Close	$36
Price Target Difference Price Target Difference n/a Close	24.2%
Analyst Consensus Analyst Consensus n/a Close	Hold
Analyst Count Analyst Count n/a Close	1

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value Lynch Fair Value n/a Close	$11
Lynch Upside Lynch Upside n/a Close	-62.06%
Graham Number Graham Number n/a Close	37.21
Graham Upside Graham Upside n/a Close	28.35%

Stock Splits

The last stock split was on Nov 23, 2016. It was a forward split with a ratio of 2:1.

Last Split Date Last Split Date n/a Close	Nov 23, 2016
Split Type Split Type n/a Close	forward
Split Ratio Split Ratio n/a Close	2:1

Scores

Altman Z-Score Altman Z-Score n/a Close	4.66
Piotroski F-Score Piotroski F-Score n/a Close	5